Please Wait
Applying Filters...
menu
    • menu
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Lorundrostat

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mineralys Presents Lorundrostat Phase 3 Launch-HTN Data at ESH
    Mineralys Presents Lorundrostat Phase 3 Launch-HTN Data at ESH

    18 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/18/3297012/0/en/mineralys-therapeutics-announces-presentation-of-new-data-from-the-phase-3-launch-htn-trial-of-lorundrostat-at-the-35th-european-meeting-on-hypertension-and-cardiovascular-protecti.html

    GLOBENEWSWIRE
    18 May 2026
    Share Share
    Mineralys Reports First Quarter 2026 Financial Results and Update
    Mineralys Reports First Quarter 2026 Financial Results and Update

    06 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/06/3289320/0/en/mineralys-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update.html

    GLOBENEWSWIRE
    06 May 2026
    Share Share
    Mineralys Therapeutics' Lorundrostat NDA Accepted By FDA
    Mineralys Therapeutics' Lorundrostat NDA Accepted By FDA

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3252329/0/en/Mineralys-Therapeutics-Announces-FDA-Acceptance-of-NDA-for-Lorundrostat-for-Treatment-of-Adults-with-Hypertension-and-Topline-Explore-OSA-Trial-Results.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share
    Mineralys Therapeutics Updates And Joins Lifesci Partners Event
    Mineralys Therapeutics Updates And Joins Lifesci Partners Event

    06 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/06/3213547/0/en/Mineralys-Therapeutics-Provides-Corporate-Update-and-Announces-Participation-in-Upcoming-LifeSci-Partners-Corporate-Access-Event-in-January-2026.html

    GLOBENEWSWIRE
    06 Jan 2026
    Share Share
    Mineralys Therapeutics Launches Lorundrostat Phase 3 HTN Trial
    Mineralys Therapeutics Launches Lorundrostat Phase 3 HTN Trial

    12 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/12/3204783/0/en/Mineralys-Therapeutics-Phase-3-Launch-HTN-Trial-of-Lorundrostat-Recognized-in-Inaugural-Journal-of-the-American-Medical-Association-JAMA-Research-of-the-Year-Roundup.html

    GLOBENEWSWIRE
    12 Dec 2025
    Share Share
    Lorundrostat Data In Chronic Kidney Disease at ASN Kidney Week
    Lorundrostat Data In Chronic Kidney Disease at ASN Kidney Week

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3184015/0/en/Data-for-Lorundrostat-in-Chronic-Kidney-Disease-and-Hypertension-Presented-at-American-Society-of-Nephrology-ASN-Kidney-Week-2025.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.